 Barry Rumack
Concepts (688)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acetaminophen | 67 | 2025 | 246 | 9.500 |
Why?
| | Analgesics, Non-Narcotic | 21 | 2025 | 119 | 6.370 |
Why?
| | Chemical and Drug Induced Liver Injury | 31 | 2024 | 132 | 5.520 |
Why?
| | Acetylcysteine | 35 | 2024 | 146 | 4.570 |
Why?
| | Drug Overdose | 27 | 2025 | 322 | 4.210 |
Why?
| | Antidotes | 24 | 2024 | 136 | 2.890 |
Why?
| | Poisoning | 25 | 2012 | 111 | 1.230 |
Why?
| | Nomograms | 4 | 2019 | 47 | 1.080 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 2 | 2023 | 253 | 0.870 |
Why?
| | Antiemetics | 1 | 2024 | 41 | 0.860 |
Why?
| | Poisons | 1 | 2023 | 20 | 0.830 |
Why?
| | Poison Control Centers | 17 | 2025 | 89 | 0.810 |
Why?
| | Canada | 6 | 2025 | 350 | 0.760 |
Why?
| | Alanine Transaminase | 8 | 2022 | 153 | 0.740 |
Why?
| | End Stage Liver Disease | 1 | 2021 | 78 | 0.650 |
Why?
| | Liver | 23 | 2023 | 1839 | 0.600 |
Why?
| | Humans | 203 | 2025 | 129650 | 0.580 |
Why?
| | Anaphylaxis | 1 | 2018 | 98 | 0.520 |
Why?
| | Cyanides | 9 | 1993 | 51 | 0.510 |
Why?
| | Decision Support Techniques | 1 | 2019 | 396 | 0.470 |
Why?
| | Nonprescription Drugs | 4 | 2008 | 66 | 0.440 |
Why?
| | Free Radical Scavengers | 2 | 2012 | 83 | 0.410 |
Why?
| | Sodium Nitrite | 7 | 1997 | 39 | 0.400 |
Why?
| | Mushroom Poisoning | 4 | 2019 | 6 | 0.400 |
Why?
| | Charcoal | 12 | 1999 | 24 | 0.390 |
Why?
| | Iatrogenic Disease | 1 | 2012 | 54 | 0.370 |
Why?
| | Plant Poisoning | 6 | 1988 | 9 | 0.360 |
Why?
| | Medication Errors | 1 | 2012 | 95 | 0.360 |
Why?
| | Adult | 72 | 2023 | 35576 | 0.360 |
Why?
| | Retrospective Studies | 14 | 2023 | 14518 | 0.350 |
Why?
| | Adolescent | 43 | 2020 | 20393 | 0.330 |
Why?
| | Environmental Exposure | 7 | 2012 | 462 | 0.320 |
Why?
| | Male | 86 | 2022 | 63681 | 0.320 |
Why?
| | Protective Agents | 2 | 2020 | 39 | 0.320 |
Why?
| | Nasal Decongestants | 1 | 2008 | 8 | 0.310 |
Why?
| | Cytochrome P-450 CYP2E1 | 4 | 2023 | 25 | 0.310 |
Why?
| | Common Cold | 1 | 2008 | 13 | 0.310 |
Why?
| | Antitussive Agents | 1 | 2008 | 7 | 0.310 |
Why?
| | Multicenter Studies as Topic | 3 | 2024 | 286 | 0.310 |
Why?
| | Time Factors | 21 | 2021 | 6556 | 0.300 |
Why?
| | Nitrites | 5 | 1989 | 83 | 0.300 |
Why?
| | Cough | 1 | 2008 | 116 | 0.290 |
Why?
| | Alcohol Drinking | 2 | 2012 | 764 | 0.280 |
Why?
| | Hyperbaric Oxygenation | 5 | 1991 | 38 | 0.260 |
Why?
| | Hepatocytes | 4 | 2022 | 216 | 0.260 |
Why?
| | Hydrogen Sulfide | 3 | 1997 | 42 | 0.250 |
Why?
| | Child | 42 | 2023 | 20883 | 0.250 |
Why?
| | Female | 73 | 2022 | 68776 | 0.240 |
Why?
| | Administration, Oral | 11 | 2019 | 786 | 0.240 |
Why?
| | Infant | 36 | 2012 | 9024 | 0.230 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 3 | 2020 | 161 | 0.230 |
Why?
| | Child, Preschool | 38 | 2014 | 10517 | 0.230 |
Why?
| | Databases, Factual | 6 | 2019 | 1269 | 0.230 |
Why?
| | Ibuprofen | 3 | 1992 | 81 | 0.230 |
Why?
| | Potassium Cyanide | 3 | 1989 | 18 | 0.220 |
Why?
| | Young Adult | 9 | 2023 | 12426 | 0.220 |
Why?
| | Ethanol | 9 | 2012 | 589 | 0.220 |
Why?
| | Infusions, Intravenous | 5 | 2019 | 400 | 0.220 |
Why?
| | Pain | 2 | 2020 | 789 | 0.220 |
Why?
| | Risk Assessment | 3 | 2024 | 3240 | 0.220 |
Why?
| | Plants, Medicinal | 3 | 1989 | 22 | 0.220 |
Why?
| | Drug Information Services | 6 | 1988 | 9 | 0.220 |
Why?
| | Liver Failure, Acute | 1 | 2024 | 64 | 0.210 |
Why?
| | Aspirin | 8 | 1989 | 380 | 0.210 |
Why?
| | Triage | 1 | 2025 | 206 | 0.200 |
Why?
| | Imines | 1 | 2022 | 8 | 0.200 |
Why?
| | Free Radicals | 2 | 1993 | 106 | 0.200 |
Why?
| | Alcoholism | 5 | 2000 | 766 | 0.200 |
Why?
| | Benzoquinones | 1 | 2022 | 48 | 0.190 |
Why?
| | Suicide, Attempted | 12 | 1990 | 349 | 0.190 |
Why?
| | Salicylates | 7 | 1989 | 30 | 0.190 |
Why?
| | Exchange Transfusion, Whole Blood | 2 | 1992 | 14 | 0.180 |
Why?
| | Ipecac | 6 | 1990 | 8 | 0.180 |
Why?
| | Thiosulfates | 4 | 1993 | 19 | 0.180 |
Why?
| | United States | 16 | 2025 | 13903 | 0.180 |
Why?
| | Liver Function Tests | 3 | 2012 | 112 | 0.180 |
Why?
| | Physostigmine | 6 | 1983 | 12 | 0.180 |
Why?
| | Hypotension | 5 | 1989 | 116 | 0.170 |
Why?
| | Time-to-Treatment | 2 | 2019 | 180 | 0.170 |
Why?
| | Coma | 9 | 1990 | 32 | 0.170 |
Why?
| | Cytochrome P-450 CYP2E1 Inhibitors | 1 | 2019 | 2 | 0.170 |
Why?
| | Seizures | 6 | 1991 | 402 | 0.170 |
Why?
| | Emergency Medical Services | 2 | 2025 | 522 | 0.160 |
Why?
| | Emergencies | 6 | 1989 | 155 | 0.160 |
Why?
| | Ambulatory Care | 1 | 2023 | 504 | 0.160 |
Why?
| | Acute Kidney Injury | 4 | 2020 | 790 | 0.160 |
Why?
| | Electric Power Supplies | 3 | 1992 | 49 | 0.160 |
Why?
| | Evidence-Based Medicine | 1 | 2023 | 718 | 0.160 |
Why?
| | Agaricales | 1 | 2018 | 3 | 0.160 |
Why?
| | Metabolome | 1 | 2022 | 338 | 0.160 |
Why?
| | Smoke Inhalation Injury | 2 | 1989 | 23 | 0.150 |
Why?
| | Fever | 2 | 2000 | 298 | 0.150 |
Why?
| | Emetics | 5 | 1984 | 7 | 0.150 |
Why?
| | Magnesium | 3 | 1988 | 153 | 0.150 |
Why?
| | Foreign Bodies | 3 | 1992 | 101 | 0.150 |
Why?
| | Administration, Intravenous | 2 | 2016 | 141 | 0.150 |
Why?
| | Excipients | 2 | 1988 | 52 | 0.150 |
Why?
| | Histamine Antagonists | 1 | 2018 | 20 | 0.150 |
Why?
| | Drug Monitoring | 1 | 1999 | 216 | 0.140 |
Why?
| | Cathartics | 4 | 1992 | 15 | 0.140 |
Why?
| | Information Systems | 4 | 2010 | 61 | 0.140 |
Why?
| | Dermatitis, Contact | 2 | 1989 | 17 | 0.140 |
Why?
| | Prothrombin Time | 3 | 1993 | 33 | 0.140 |
Why?
| | Glutathione | 5 | 2022 | 348 | 0.140 |
Why?
| | Sex Factors | 5 | 2022 | 1968 | 0.140 |
Why?
| | Phenytoin | 3 | 2004 | 20 | 0.130 |
Why?
| | Middle Aged | 22 | 2023 | 31154 | 0.130 |
Why?
| | Occupational Diseases | 2 | 1990 | 138 | 0.130 |
Why?
| | Hospital Mortality | 1 | 2021 | 850 | 0.130 |
Why?
| | Hospitals | 1 | 2021 | 637 | 0.130 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 303 | 0.130 |
Why?
| | Drug Interactions | 4 | 2019 | 394 | 0.120 |
Why?
| | Animals | 25 | 2024 | 35361 | 0.120 |
Why?
| | Amygdalin | 3 | 1986 | 3 | 0.120 |
Why?
| | Cimetidine | 1 | 1995 | 13 | 0.120 |
Why?
| | Toxicology | 3 | 1990 | 41 | 0.120 |
Why?
| | Patient Selection | 1 | 2019 | 663 | 0.120 |
Why?
| | 3,4-Methylenedioxyamphetamine | 2 | 1987 | 2 | 0.120 |
Why?
| | Amphetamines | 2 | 1987 | 4 | 0.120 |
Why?
| | Arsenic Poisoning | 2 | 1989 | 7 | 0.120 |
Why?
| | Drug Administration Schedule | 4 | 2014 | 769 | 0.110 |
Why?
| | Aspartate Aminotransferases | 6 | 2002 | 88 | 0.110 |
Why?
| | Treatment Outcome | 3 | 2018 | 10230 | 0.110 |
Why?
| | Cohort Studies | 2 | 2018 | 5420 | 0.110 |
Why?
| | Riots | 1 | 1993 | 2 | 0.110 |
Why?
| | Psychophysiologic Disorders | 1 | 1993 | 10 | 0.110 |
Why?
| | Societies | 5 | 2012 | 38 | 0.110 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 1952 | 0.110 |
Why?
| | Risk | 5 | 2009 | 854 | 0.110 |
Why?
| | Mice, Inbred C57BL | 5 | 2023 | 5440 | 0.110 |
Why?
| | Risk Factors | 4 | 2019 | 9765 | 0.100 |
Why?
| | Acute Disease | 8 | 1993 | 980 | 0.100 |
Why?
| | Protein Kinase Inhibitors | 1 | 2019 | 891 | 0.100 |
Why?
| | Hydrocarbons, Halogenated | 1 | 1993 | 5 | 0.100 |
Why?
| | Methemoglobin | 3 | 1989 | 20 | 0.100 |
Why?
| | Carbon Tetrachloride | 1 | 1993 | 13 | 0.100 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2742 | 0.100 |
Why?
| | Prospective Studies | 11 | 2020 | 7133 | 0.100 |
Why?
| | Xenobiotics | 1 | 2012 | 29 | 0.100 |
Why?
| | Phenobarbital | 4 | 2004 | 19 | 0.100 |
Why?
| | Electrolytes | 2 | 1990 | 60 | 0.100 |
Why?
| | United States Food and Drug Administration | 2 | 2012 | 204 | 0.100 |
Why?
| | Prognosis | 3 | 2019 | 3794 | 0.100 |
Why?
| | Warfarin | 1 | 1993 | 147 | 0.100 |
Why?
| | Digestive System | 1 | 1992 | 29 | 0.100 |
Why?
| | Hydrocarbons | 2 | 1986 | 27 | 0.100 |
Why?
| | Life Change Events | 1 | 1993 | 148 | 0.100 |
Why?
| | Drug Dosage Calculations | 1 | 2012 | 22 | 0.100 |
Why?
| | Vascular Headaches | 1 | 1991 | 1 | 0.100 |
Why?
| | Fluoride Poisoning | 1 | 1991 | 3 | 0.100 |
Why?
| | Genetic Predisposition to Disease | 1 | 2020 | 2282 | 0.100 |
Why?
| | Bromocriptine | 1 | 1991 | 29 | 0.090 |
Why?
| | Sympathomimetics | 1 | 1991 | 23 | 0.090 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1838 | 0.090 |
Why?
| | Carbon Tetrachloride Poisoning | 1 | 1991 | 2 | 0.090 |
Why?
| | Gas Poisoning | 2 | 1993 | 4 | 0.090 |
Why?
| | Magnesium Sulfate | 2 | 1988 | 18 | 0.090 |
Why?
| | Hydroxocobalamin | 2 | 1993 | 26 | 0.090 |
Why?
| | Methemoglobinemia | 3 | 1986 | 13 | 0.090 |
Why?
| | Incidence | 1 | 2018 | 2644 | 0.090 |
Why?
| | Methanol | 1 | 1991 | 35 | 0.090 |
Why?
| | Half-Life | 8 | 1992 | 162 | 0.090 |
Why?
| | Vancomycin | 1 | 1992 | 78 | 0.090 |
Why?
| | Information Services | 3 | 1990 | 47 | 0.090 |
Why?
| | Gastric Lavage | 6 | 1992 | 9 | 0.090 |
Why?
| | Kinetics | 13 | 1987 | 1642 | 0.090 |
Why?
| | Sulfates | 1 | 1990 | 50 | 0.090 |
Why?
| | Pyridoxine | 1 | 1990 | 32 | 0.090 |
Why?
| | Therapeutic Irrigation | 1 | 1990 | 75 | 0.090 |
Why?
| | Amphotericin B | 1 | 1990 | 29 | 0.080 |
Why?
| | Interior Design and Furnishings | 1 | 1990 | 4 | 0.080 |
Why?
| | Alcoholic Intoxication | 2 | 1988 | 63 | 0.080 |
Why?
| | Liver Diseases | 4 | 2002 | 290 | 0.080 |
Why?
| | Pregnancy Complications | 2 | 1989 | 493 | 0.080 |
Why?
| | Methylene Chloride | 1 | 1990 | 4 | 0.080 |
Why?
| | Naloxone | 4 | 1985 | 112 | 0.080 |
Why?
| | Hydrofluoric Acid | 2 | 1989 | 8 | 0.080 |
Why?
| | Facility Design and Construction | 1 | 1990 | 12 | 0.080 |
Why?
| | Isoniazid | 1 | 1990 | 63 | 0.080 |
Why?
| | Societies, Scientific | 1 | 1990 | 45 | 0.080 |
Why?
| | Substance-Related Disorders | 4 | 1987 | 1022 | 0.080 |
Why?
| | Phenelzine | 2 | 1987 | 4 | 0.080 |
Why?
| | Hydrocarbons, Chlorinated | 1 | 1990 | 23 | 0.080 |
Why?
| | Rodenticides | 1 | 1989 | 4 | 0.080 |
Why?
| | 4-Hydroxycoumarins | 1 | 1989 | 4 | 0.080 |
Why?
| | Penicillamine | 5 | 1986 | 23 | 0.080 |
Why?
| | Mycoses | 1 | 1990 | 71 | 0.080 |
Why?
| | Plants, Toxic | 2 | 1987 | 22 | 0.080 |
Why?
| | Hospitalization | 2 | 2019 | 2070 | 0.080 |
Why?
| | Sodium Compounds | 1 | 1989 | 4 | 0.080 |
Why?
| | Arsenites | 1 | 1989 | 5 | 0.080 |
Why?
| | Eucalyptus | 1 | 1989 | 7 | 0.080 |
Why?
| | Plant Oils | 1 | 1989 | 29 | 0.080 |
Why?
| | Thyroxine | 2 | 1987 | 62 | 0.080 |
Why?
| | Chlorambucil | 1 | 1988 | 9 | 0.080 |
Why?
| | Iron | 1 | 1991 | 288 | 0.080 |
Why?
| | Reproducibility of Results | 1 | 2016 | 3083 | 0.080 |
Why?
| | Antioxidants | 2 | 1993 | 559 | 0.080 |
Why?
| | Construction Materials | 2 | 1986 | 13 | 0.080 |
Why?
| | Trees | 1 | 1989 | 69 | 0.080 |
Why?
| | Writing | 1 | 1990 | 91 | 0.080 |
Why?
| | Alprazolam | 1 | 1988 | 6 | 0.080 |
Why?
| | Captopril | 1 | 1988 | 10 | 0.080 |
Why?
| | Perfume | 1 | 1988 | 4 | 0.080 |
Why?
| | Botany | 1 | 1988 | 2 | 0.080 |
Why?
| | Critical Pathways | 1 | 2009 | 80 | 0.070 |
Why?
| | Adverse Drug Reaction Reporting Systems | 1 | 2008 | 74 | 0.070 |
Why?
| | Vomiting | 3 | 1988 | 128 | 0.070 |
Why?
| | Chewing Gum | 1 | 1988 | 9 | 0.070 |
Why?
| | Heart Diseases | 1 | 1991 | 350 | 0.070 |
Why?
| | Diflunisal | 1 | 1987 | 2 | 0.070 |
Why?
| | Sweetening Agents | 1 | 1988 | 39 | 0.070 |
Why?
| | Fabaceae | 1 | 1988 | 12 | 0.070 |
Why?
| | Polyethylene Glycols | 2 | 1990 | 601 | 0.070 |
Why?
| | Intestinal Absorption | 3 | 1999 | 99 | 0.070 |
Why?
| | Blood Coagulation Disorders | 1 | 1989 | 167 | 0.070 |
Why?
| | Imipramine | 3 | 1979 | 12 | 0.070 |
Why?
| | Fruit | 1 | 1988 | 131 | 0.070 |
Why?
| | International System of Units | 1 | 1987 | 2 | 0.070 |
Why?
| | Medication Systems | 1 | 1987 | 3 | 0.070 |
Why?
| | Theophylline | 1 | 1987 | 68 | 0.070 |
Why?
| | Zinc | 1 | 1990 | 294 | 0.070 |
Why?
| | Weights and Measures | 1 | 1987 | 7 | 0.070 |
Why?
| | Basidiomycota | 1 | 1987 | 28 | 0.070 |
Why?
| | Quinine | 1 | 1987 | 16 | 0.070 |
Why?
| | Arrhythmias, Cardiac | 3 | 1981 | 317 | 0.070 |
Why?
| | Aged | 8 | 2020 | 22103 | 0.070 |
Why?
| | Drug Therapy, Combination | 3 | 2002 | 1040 | 0.070 |
Why?
| | Mistletoe | 1 | 1986 | 2 | 0.070 |
Why?
| | Antidepressive Agents, Tricyclic | 1 | 1987 | 30 | 0.070 |
Why?
| | Pharmacy Service, Hospital | 1 | 1988 | 90 | 0.070 |
Why?
| | Blindness | 1 | 1987 | 38 | 0.070 |
Why?
| | Clonidine | 2 | 1983 | 27 | 0.070 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2012 | 1368 | 0.070 |
Why?
| | Thiazines | 1 | 1986 | 9 | 0.060 |
Why?
| | Population Surveillance | 4 | 2011 | 439 | 0.060 |
Why?
| | Magnesium Compounds | 1 | 1986 | 2 | 0.060 |
Why?
| | Xylazine | 1 | 1986 | 14 | 0.060 |
Why?
| | Aluminum Compounds | 1 | 1986 | 6 | 0.060 |
Why?
| | Epinephrine | 1 | 1987 | 141 | 0.060 |
Why?
| | Boric Acids | 1 | 1986 | 1 | 0.060 |
Why?
| | Silicates | 1 | 1986 | 15 | 0.060 |
Why?
| | Atropine | 4 | 1987 | 24 | 0.060 |
Why?
| | Microsomes, Liver | 4 | 1976 | 87 | 0.060 |
Why?
| | Oxidoreductases | 3 | 1986 | 92 | 0.060 |
Why?
| | Yohimbine | 1 | 1985 | 9 | 0.060 |
Why?
| | Infant, Newborn | 8 | 2008 | 5762 | 0.060 |
Why?
| | Guanabenz | 1 | 1985 | 1 | 0.060 |
Why?
| | Amitriptyline | 3 | 1983 | 20 | 0.060 |
Why?
| | Guanidines | 1 | 1985 | 36 | 0.060 |
Why?
| | Accidents, Home | 5 | 1988 | 29 | 0.060 |
Why?
| | Pancreatitis | 1 | 1986 | 129 | 0.060 |
Why?
| | Gastric Emptying | 1 | 1985 | 40 | 0.060 |
Why?
| | Nicotine | 1 | 1988 | 303 | 0.060 |
Why?
| | Substance Withdrawal Syndrome | 3 | 1985 | 176 | 0.060 |
Why?
| | Bronchodilator Agents | 1 | 1987 | 243 | 0.060 |
Why?
| | Chlorobenzenes | 1 | 1985 | 9 | 0.060 |
Why?
| | Injections, Intravenous | 4 | 1991 | 201 | 0.060 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 1993 | 825 | 0.060 |
Why?
| | Marine Toxins | 1 | 1985 | 12 | 0.060 |
Why?
| | Kidney | 3 | 2023 | 1385 | 0.060 |
Why?
| | Mice | 4 | 2023 | 16937 | 0.060 |
Why?
| | Insecticides | 1 | 1985 | 33 | 0.060 |
Why?
| | Morphinans | 3 | 1973 | 8 | 0.060 |
Why?
| | Naphthalenes | 1 | 1985 | 57 | 0.060 |
Why?
| | Computers | 2 | 1988 | 65 | 0.060 |
Why?
| | Lactones | 1 | 1985 | 58 | 0.060 |
Why?
| | Bacterial Toxins | 1 | 1985 | 106 | 0.060 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2014 | 2012 | 0.060 |
Why?
| | Cyanobacteria | 1 | 1985 | 55 | 0.060 |
Why?
| | Medical History Taking | 2 | 1999 | 119 | 0.050 |
Why?
| | Heroin | 1 | 1984 | 30 | 0.050 |
Why?
| | Deglutition | 1 | 1984 | 67 | 0.050 |
Why?
| | Delphi Technique | 1 | 2025 | 225 | 0.050 |
Why?
| | Household Products | 1 | 1983 | 6 | 0.050 |
Why?
| | Ethylene Glycols | 1 | 1983 | 15 | 0.050 |
Why?
| | Cognition Disorders | 1 | 1987 | 505 | 0.050 |
Why?
| | Copper | 1 | 1984 | 109 | 0.050 |
Why?
| | Online Systems | 1 | 1983 | 21 | 0.050 |
Why?
| | Talc | 1 | 1982 | 7 | 0.050 |
Why?
| | Drug Labeling | 2 | 2000 | 41 | 0.050 |
Why?
| | Barbiturates | 2 | 2002 | 6 | 0.050 |
Why?
| | Oxidation-Reduction | 2 | 2019 | 1033 | 0.050 |
Why?
| | Infant Care | 1 | 1982 | 46 | 0.050 |
Why?
| | Hallucinations | 4 | 1979 | 29 | 0.050 |
Why?
| | Lactates | 1 | 2022 | 85 | 0.050 |
Why?
| | Pharmaceutical Preparations | 1 | 1984 | 171 | 0.050 |
Why?
| | Phenylurea Compounds | 1 | 2022 | 89 | 0.050 |
Why?
| | Enzyme Induction | 1 | 2002 | 90 | 0.050 |
Why?
| | Consensus | 1 | 2025 | 616 | 0.050 |
Why?
| | Phenylpropanolamine | 3 | 1982 | 3 | 0.050 |
Why?
| | Transaminases | 2 | 2014 | 23 | 0.050 |
Why?
| | Hemorrhage | 1 | 1986 | 678 | 0.050 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2002 | 53 | 0.050 |
Why?
| | Phencyclidine Abuse | 1 | 1980 | 1 | 0.040 |
Why?
| | Colorado | 7 | 1992 | 4421 | 0.040 |
Why?
| | Cross-Sectional Studies | 1 | 2012 | 5066 | 0.040 |
Why?
| | Stomach | 4 | 1988 | 109 | 0.040 |
Why?
| | Fluid Therapy | 3 | 1988 | 134 | 0.040 |
Why?
| | Pharmacology | 1 | 2000 | 9 | 0.040 |
Why?
| | Activation, Metabolic | 1 | 2019 | 4 | 0.040 |
Why?
| | Anticonvulsants | 1 | 2002 | 209 | 0.040 |
Why?
| | Methapyrilene | 1 | 1979 | 1 | 0.040 |
Why?
| | Salicylamides | 1 | 1979 | 3 | 0.040 |
Why?
| | Immune System | 1 | 2020 | 175 | 0.040 |
Why?
| | Psychology, Child | 1 | 1979 | 36 | 0.040 |
Why?
| | Drug Compounding | 1 | 1999 | 97 | 0.040 |
Why?
| | Molecular Docking Simulation | 1 | 2019 | 109 | 0.040 |
Why?
| | Clinical Trials as Topic | 2 | 2000 | 1004 | 0.040 |
Why?
| | Pediatrics | 1 | 1987 | 1052 | 0.040 |
Why?
| | Digoxin | 2 | 1979 | 27 | 0.040 |
Why?
| | Age Factors | 4 | 1999 | 3144 | 0.040 |
Why?
| | Lipids | 1 | 2022 | 625 | 0.040 |
Why?
| | Aminopyridines | 1 | 1979 | 97 | 0.040 |
Why?
| | Evaluation Studies as Topic | 4 | 1988 | 173 | 0.040 |
Why?
| | Critical Care | 1 | 1983 | 553 | 0.040 |
Why?
| | Mitochondria | 1 | 2023 | 877 | 0.030 |
Why?
| | Cross-Over Studies | 1 | 2019 | 521 | 0.030 |
Why?
| | Infant, Newborn, Diseases | 2 | 1981 | 110 | 0.030 |
Why?
| | Heart Arrest | 1 | 1981 | 321 | 0.030 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 1986 | 1565 | 0.030 |
Why?
| | Caustics | 1 | 1977 | 7 | 0.030 |
Why?
| | Child Behavior | 1 | 1979 | 235 | 0.030 |
Why?
| | Metabolic Clearance Rate | 2 | 1987 | 118 | 0.030 |
Why?
| | Fatal Outcome | 1 | 1997 | 300 | 0.030 |
Why?
| | Calcium Gluconate | 2 | 1989 | 4 | 0.030 |
Why?
| | Protein Binding | 3 | 2019 | 2121 | 0.030 |
Why?
| | Glutethimide | 2 | 1979 | 3 | 0.030 |
Why?
| | Hypertension | 4 | 1987 | 1242 | 0.030 |
Why?
| | Genetic Variation | 1 | 2020 | 937 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1587 | 0.030 |
Why?
| | Kidney Diseases | 2 | 1992 | 384 | 0.030 |
Why?
| | Ethchlorvynol | 2 | 1979 | 2 | 0.030 |
Why?
| | Heart Rate | 3 | 1993 | 802 | 0.030 |
Why?
| | Central Nervous System | 3 | 1986 | 257 | 0.030 |
Why?
| | Apoptosis | 1 | 2023 | 2503 | 0.030 |
Why?
| | Isonipecotic Acids | 1 | 1974 | 1 | 0.030 |
Why?
| | Clomipramine | 1 | 1974 | 2 | 0.030 |
Why?
| | Dibenzazepines | 1 | 1974 | 4 | 0.030 |
Why?
| | Chemistry | 4 | 1985 | 44 | 0.030 |
Why?
| | Chemical Phenomena | 4 | 1985 | 81 | 0.030 |
Why?
| | Central Nervous System Diseases | 2 | 1987 | 68 | 0.030 |
Why?
| | Dopamine | 2 | 1988 | 289 | 0.030 |
Why?
| | Protein Deficiency | 1 | 1973 | 3 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2020 | 1333 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2021 | 2391 | 0.030 |
Why?
| | Parasympatholytics | 1 | 1973 | 12 | 0.030 |
Why?
| | Quaternary Ammonium Compounds | 1 | 1974 | 53 | 0.030 |
Why?
| | Georgia (Republic) | 1 | 1993 | 3 | 0.030 |
Why?
| | Gastrointestinal Agents | 1 | 1974 | 61 | 0.030 |
Why?
| | Civil Rights | 1 | 1993 | 8 | 0.030 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 1973 | 16 | 0.030 |
Why?
| | Conversion Disorder | 1 | 1993 | 9 | 0.030 |
Why?
| | Diquat | 1 | 1993 | 1 | 0.030 |
Why?
| | Animals, Domestic | 1 | 2012 | 14 | 0.030 |
Why?
| | Amoxapine | 2 | 1982 | 2 | 0.030 |
Why?
| | Dibenzoxazepines | 2 | 1982 | 2 | 0.030 |
Why?
| | Mercury Poisoning | 2 | 1983 | 6 | 0.030 |
Why?
| | Injections, Intramuscular | 2 | 1986 | 116 | 0.030 |
Why?
| | Drug Combinations | 4 | 1993 | 330 | 0.020 |
Why?
| | Pregnancy | 6 | 1989 | 6402 | 0.020 |
Why?
| | Dietary Proteins | 1 | 1973 | 129 | 0.020 |
Why?
| | Treatment Failure | 1 | 1993 | 340 | 0.020 |
Why?
| | Fluorides, Topical | 1 | 1991 | 13 | 0.020 |
Why?
| | Ear Diseases | 1 | 1992 | 14 | 0.020 |
Why?
| | Accidents | 1 | 1991 | 39 | 0.020 |
Why?
| | Electrocardiography | 4 | 1983 | 608 | 0.020 |
Why?
| | Transferrin | 1 | 1991 | 42 | 0.020 |
Why?
| | Lactoferrin | 1 | 1991 | 28 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 1982 | 1902 | 0.020 |
Why?
| | Bicarbonates | 1 | 1991 | 42 | 0.020 |
Why?
| | Ferritins | 1 | 1991 | 58 | 0.020 |
Why?
| | Algorithms | 1 | 2018 | 1622 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 1993 | 529 | 0.020 |
Why?
| | Hemoperfusion | 3 | 1979 | 3 | 0.020 |
Why?
| | Zinc Sulfate | 1 | 1990 | 8 | 0.020 |
Why?
| | Administration, Rectal | 1 | 1990 | 11 | 0.020 |
Why?
| | Urography | 1 | 1990 | 16 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2018 | 4083 | 0.020 |
Why?
| | Anticoagulants | 2 | 1989 | 637 | 0.020 |
Why?
| | Lactation | 1 | 1991 | 170 | 0.020 |
Why?
| | Physicians | 2 | 1993 | 865 | 0.020 |
Why?
| | Disease Outbreaks | 1 | 1993 | 349 | 0.020 |
Why?
| | Dimercaprol | 2 | 1981 | 6 | 0.020 |
Why?
| | Protective Devices | 1 | 1990 | 29 | 0.020 |
Why?
| | Biomarkers | 1 | 2021 | 3973 | 0.020 |
Why?
| | Creatinine | 1 | 1992 | 491 | 0.020 |
Why?
| | Amyl Nitrite | 1 | 1989 | 1 | 0.020 |
Why?
| | Skin | 4 | 1989 | 725 | 0.020 |
Why?
| | Ventilators, Mechanical | 1 | 1990 | 56 | 0.020 |
Why?
| | Fetal Death | 1 | 1989 | 56 | 0.020 |
Why?
| | Carboxyhemoglobin | 1 | 1989 | 5 | 0.020 |
Why?
| | Therapeutic Equivalency | 1 | 1989 | 30 | 0.020 |
Why?
| | Apnea | 2 | 1986 | 20 | 0.020 |
Why?
| | Cytochrome-B(5) Reductase | 2 | 1986 | 2 | 0.020 |
Why?
| | Abortion, Spontaneous | 1 | 1989 | 100 | 0.020 |
Why?
| | Congresses as Topic | 1 | 1990 | 216 | 0.020 |
Why?
| | Physician-Patient Relations | 1 | 1993 | 539 | 0.020 |
Why?
| | Acidosis | 1 | 1989 | 89 | 0.020 |
Why?
| | Tablets | 1 | 1988 | 36 | 0.020 |
Why?
| | Arsenic | 1 | 1989 | 66 | 0.020 |
Why?
| | Information Centers | 1 | 1988 | 4 | 0.020 |
Why?
| | Tobacco, Smokeless | 1 | 1988 | 10 | 0.020 |
Why?
| | Dogs | 2 | 1987 | 381 | 0.020 |
Why?
| | Survival Rate | 1 | 2012 | 1877 | 0.020 |
Why?
| | Salicylic Acid | 1 | 1987 | 8 | 0.020 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 1989 | 121 | 0.020 |
Why?
| | Peripheral Nervous System Diseases | 1 | 1989 | 126 | 0.020 |
Why?
| | Thirst | 1 | 1987 | 5 | 0.020 |
Why?
| | Pulse | 1 | 1987 | 23 | 0.020 |
Why?
| | Bile | 1 | 1987 | 35 | 0.020 |
Why?
| | Saponins | 1 | 1987 | 8 | 0.020 |
Why?
| | Diagnosis, Differential | 2 | 1987 | 1434 | 0.020 |
Why?
| | Cysteamine | 2 | 1978 | 7 | 0.020 |
Why?
| | N-Methyl-3,4-methylenedioxyamphetamine | 1 | 1987 | 10 | 0.020 |
Why?
| | Maternal-Fetal Exchange | 2 | 1981 | 161 | 0.020 |
Why?
| | Carrier Proteins | 1 | 1991 | 743 | 0.020 |
Why?
| | Arousal | 1 | 1987 | 150 | 0.020 |
Why?
| | Keratoconjunctivitis | 1 | 1986 | 5 | 0.020 |
Why?
| | Lighting | 1 | 1986 | 24 | 0.020 |
Why?
| | Infant, Premature | 2 | 1981 | 541 | 0.020 |
Why?
| | Hemoglobin M | 1 | 1986 | 2 | 0.020 |
Why?
| | Mortality | 1 | 1988 | 307 | 0.020 |
Why?
| | Abdomen, Acute | 1 | 1986 | 18 | 0.020 |
Why?
| | Inactivation, Metabolic | 1 | 1986 | 11 | 0.020 |
Why?
| | NADPH-Ferrihemoprotein Reductase | 1 | 1986 | 10 | 0.020 |
Why?
| | Methylene Blue | 1 | 1986 | 23 | 0.020 |
Why?
| | Rats | 5 | 1983 | 5500 | 0.020 |
Why?
| | Ditiocarb | 1 | 1986 | 3 | 0.020 |
Why?
| | Ferrocyanides | 1 | 1986 | 4 | 0.020 |
Why?
| | Aminopropionitrile | 1 | 1986 | 2 | 0.020 |
Why?
| | Kaolin | 1 | 1986 | 4 | 0.020 |
Why?
| | Aluminum Silicates | 1 | 1986 | 12 | 0.020 |
Why?
| | Electroencephalography | 1 | 1988 | 403 | 0.020 |
Why?
| | Thioctic Acid | 1 | 1986 | 10 | 0.020 |
Why?
| | Respiratory Tract Diseases | 1 | 1987 | 148 | 0.020 |
Why?
| | Glycerides | 1 | 1986 | 20 | 0.020 |
Why?
| | Documentation | 1 | 1988 | 184 | 0.020 |
Why?
| | Carmustine | 1 | 1986 | 50 | 0.020 |
Why?
| | Dioxins | 1 | 1985 | 5 | 0.020 |
Why?
| | Polychlorinated Dibenzodioxins | 1 | 1985 | 6 | 0.020 |
Why?
| | Drug Synergism | 1 | 1987 | 371 | 0.020 |
Why?
| | Antivenins | 1 | 1986 | 35 | 0.020 |
Why?
| | Intubation, Gastrointestinal | 1 | 1986 | 77 | 0.020 |
Why?
| | Latex | 1 | 1985 | 9 | 0.020 |
Why?
| | Triiodothyronine | 1 | 1985 | 44 | 0.020 |
Why?
| | Propylene Glycols | 1 | 1985 | 27 | 0.020 |
Why?
| | Gastrointestinal Diseases | 1 | 1987 | 198 | 0.020 |
Why?
| | Niacinamide | 1 | 1986 | 75 | 0.020 |
Why?
| | Respiration | 1 | 1986 | 191 | 0.020 |
Why?
| | Smoking | 1 | 1993 | 1501 | 0.020 |
Why?
| | Sleep Stages | 1 | 1985 | 45 | 0.010 |
Why?
| | Irritants | 1 | 1985 | 48 | 0.010 |
Why?
| | Turpentine | 1 | 1985 | 5 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 1988 | 1206 | 0.010 |
Why?
| | Microcystins | 1 | 1985 | 7 | 0.010 |
Why?
| | Ivermectin | 1 | 1985 | 13 | 0.010 |
Why?
| | Brucella | 1 | 1964 | 1 | 0.010 |
Why?
| | Spheroplasts | 1 | 1964 | 2 | 0.010 |
Why?
| | Fluorouracil | 1 | 1986 | 199 | 0.010 |
Why?
| | Intestines | 1 | 1988 | 348 | 0.010 |
Why?
| | Biochemical Phenomena | 1 | 1964 | 10 | 0.010 |
Why?
| | Data Collection | 1 | 1988 | 650 | 0.010 |
Why?
| | Bradycardia | 1 | 1985 | 53 | 0.010 |
Why?
| | Chromatography, High Pressure Liquid | 3 | 1993 | 582 | 0.010 |
Why?
| | Oxygen Inhalation Therapy | 1 | 1986 | 143 | 0.010 |
Why?
| | Tachycardia | 2 | 1987 | 57 | 0.010 |
Why?
| | Cytochrome P-450 Enzyme System | 3 | 1976 | 151 | 0.010 |
Why?
| | Tissue Culture Techniques | 1 | 1964 | 74 | 0.010 |
Why?
| | Penicillins | 1 | 1964 | 57 | 0.010 |
Why?
| | Solvents | 1 | 1985 | 108 | 0.010 |
Why?
| | Biochemistry | 1 | 1964 | 38 | 0.010 |
Why?
| | Random Allocation | 1 | 1985 | 346 | 0.010 |
Why?
| | Solubility | 1 | 1985 | 235 | 0.010 |
Why?
| | Culture Media | 1 | 1964 | 162 | 0.010 |
Why?
| | Arginine | 1 | 1986 | 265 | 0.010 |
Why?
| | Burns, Chemical | 2 | 1981 | 29 | 0.010 |
Why?
| | Doxorubicin | 1 | 1986 | 325 | 0.010 |
Why?
| | Copper Sulfate | 1 | 1984 | 8 | 0.010 |
Why?
| | Homeostasis | 1 | 1988 | 611 | 0.010 |
Why?
| | Chlorpheniramine | 2 | 1974 | 6 | 0.010 |
Why?
| | Biotransformation | 1 | 1984 | 66 | 0.010 |
Why?
| | Cytoplasm | 1 | 1964 | 263 | 0.010 |
Why?
| | Radiography | 2 | 1983 | 798 | 0.010 |
Why?
| | Infusions, Parenteral | 1 | 1983 | 38 | 0.010 |
Why?
| | Ultraviolet Rays | 1 | 1986 | 383 | 0.010 |
Why?
| | Blood Pressure | 2 | 1993 | 1736 | 0.010 |
Why?
| | Drug Packaging | 1 | 1984 | 41 | 0.010 |
Why?
| | Glycine | 1 | 1964 | 165 | 0.010 |
Why?
| | Endotoxins | 1 | 1964 | 220 | 0.010 |
Why?
| | Bilirubin | 1 | 1984 | 96 | 0.010 |
Why?
| | Mercury Compounds | 1 | 1983 | 3 | 0.010 |
Why?
| | Diuresis | 2 | 1980 | 10 | 0.010 |
Why?
| | Dextropropoxyphene | 2 | 1980 | 3 | 0.010 |
Why?
| | Foreign-Body Reaction | 1 | 1983 | 27 | 0.010 |
Why?
| | Enema | 1 | 1983 | 43 | 0.010 |
Why?
| | Bacteriophages | 1 | 1964 | 93 | 0.010 |
Why?
| | Oxides | 1 | 1983 | 41 | 0.010 |
Why?
| | Mercury | 1 | 1983 | 40 | 0.010 |
Why?
| | Ephedrine | 1 | 1982 | 4 | 0.010 |
Why?
| | Phagocytosis | 1 | 1964 | 362 | 0.010 |
Why?
| | Cytochromes | 2 | 1973 | 10 | 0.010 |
Why?
| | Powders | 1 | 1982 | 43 | 0.010 |
Why?
| | Inhalation | 1 | 1982 | 28 | 0.010 |
Why?
| | History, 20th Century | 1 | 1984 | 291 | 0.010 |
Why?
| | Cysteine | 1 | 1984 | 195 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 1992 | 4897 | 0.010 |
Why?
| | Gagging | 1 | 1982 | 1 | 0.010 |
Why?
| | Caffeine | 1 | 1982 | 62 | 0.010 |
Why?
| | Seasons | 1 | 1985 | 502 | 0.010 |
Why?
| | Cattle | 1 | 1985 | 976 | 0.010 |
Why?
| | Consciousness | 1 | 1982 | 25 | 0.010 |
Why?
| | Diarrhea | 1 | 1983 | 180 | 0.010 |
Why?
| | Lethal Dose 50 | 1 | 1981 | 15 | 0.010 |
Why?
| | Gluconates | 1 | 1981 | 5 | 0.010 |
Why?
| | Reflex | 1 | 1982 | 65 | 0.010 |
Why?
| | Monocytes | 1 | 1964 | 551 | 0.010 |
Why?
| | Research | 1 | 1964 | 416 | 0.010 |
Why?
| | Carbamazepine | 1 | 1981 | 19 | 0.010 |
Why?
| | Blood Glucose | 1 | 1991 | 2097 | 0.010 |
Why?
| | Drug Evaluation | 1 | 1981 | 82 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2012 | 7086 | 0.010 |
Why?
| | Esophagus | 1 | 1983 | 248 | 0.010 |
Why?
| | Selenium | 1 | 1981 | 36 | 0.010 |
Why?
| | Cerebral Hemorrhage | 1 | 1981 | 107 | 0.010 |
Why?
| | Microchemistry | 2 | 1978 | 20 | 0.010 |
Why?
| | Polyurethanes | 1 | 1981 | 38 | 0.010 |
Why?
| | Formaldehyde | 1 | 1981 | 60 | 0.010 |
Why?
| | Urea | 1 | 1981 | 77 | 0.010 |
Why?
| | Gold | 1 | 1981 | 119 | 0.010 |
Why?
| | Enzyme Activation | 2 | 1973 | 811 | 0.010 |
Why?
| | Furosemide | 1 | 1980 | 39 | 0.010 |
Why?
| | Nurses | 1 | 1983 | 164 | 0.010 |
Why?
| | Pharmacokinetics | 1 | 2000 | 29 | 0.010 |
Why?
| | Pharmacists | 1 | 1983 | 247 | 0.010 |
Why?
| | Methods | 2 | 1977 | 64 | 0.010 |
Why?
| | Cyclohexanones | 1 | 1979 | 9 | 0.010 |
Why?
| | Oils, Volatile | 1 | 1979 | 6 | 0.010 |
Why?
| | Abortifacient Agents | 1 | 1979 | 3 | 0.010 |
Why?
| | Metabolism | 1 | 2000 | 38 | 0.010 |
Why?
| | Cyclohexanes | 1 | 1979 | 22 | 0.010 |
Why?
| | Phenothiazines | 1 | 1979 | 7 | 0.010 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 1979 | 34 | 0.010 |
Why?
| | Down Syndrome | 1 | 1986 | 481 | 0.010 |
Why?
| | Housing | 1 | 1981 | 130 | 0.010 |
Why?
| | Interprofessional Relations | 1 | 1982 | 277 | 0.010 |
Why?
| | Calcium | 1 | 1986 | 1213 | 0.010 |
Why?
| | Enuresis | 1 | 1979 | 3 | 0.010 |
Why?
| | Nitrates | 1 | 1979 | 89 | 0.010 |
Why?
| | Microfilming | 1 | 1979 | 1 | 0.010 |
Why?
| | Self Medication | 1 | 1979 | 10 | 0.010 |
Why?
| | Arthritis, Juvenile | 1 | 1979 | 53 | 0.010 |
Why?
| | Hemostasis | 1 | 1979 | 79 | 0.010 |
Why?
| | Gingival Neoplasms | 1 | 1979 | 10 | 0.010 |
Why?
| | Thiocyanates | 1 | 1979 | 31 | 0.010 |
Why?
| | Valproic Acid | 1 | 1979 | 47 | 0.010 |
Why?
| | Podophyllin | 1 | 1978 | 1 | 0.010 |
Why?
| | Necrosis | 2 | 1979 | 232 | 0.010 |
Why?
| | Pregnancy Trimester, Third | 1 | 1979 | 109 | 0.010 |
Why?
| | Mitral Valve | 1 | 1979 | 85 | 0.010 |
Why?
| | Alkaloids | 1 | 1978 | 28 | 0.010 |
Why?
| | Magnoliopsida | 1 | 1978 | 28 | 0.010 |
Why?
| | Skin Manifestations | 2 | 1975 | 2 | 0.010 |
Why?
| | Opioid-Related Disorders | 1 | 1985 | 484 | 0.010 |
Why?
| | Regional Health Planning | 1 | 1978 | 7 | 0.010 |
Why?
| | Software | 1 | 1983 | 608 | 0.010 |
Why?
| | Beverages | 1 | 1978 | 68 | 0.010 |
Why?
| | Heart Valve Prosthesis | 1 | 1979 | 112 | 0.010 |
Why?
| | Methionine | 1 | 1978 | 158 | 0.010 |
Why?
| | Transportation of Patients | 1 | 1978 | 50 | 0.010 |
Why?
| | Spectrophotometry | 2 | 1976 | 58 | 0.010 |
Why?
| | Clonazepam | 1 | 1977 | 6 | 0.010 |
Why?
| | Citrus | 1 | 1977 | 6 | 0.010 |
Why?
| | Spectrophotometry, Ultraviolet | 2 | 1976 | 84 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 1987 | 4063 | 0.010 |
Why?
| | Benzodiazepinones | 1 | 1977 | 17 | 0.010 |
Why?
| | Fetal Blood | 1 | 1979 | 316 | 0.010 |
Why?
| | Oils | 1 | 1976 | 21 | 0.010 |
Why?
| | Hypersensitivity | 1 | 1979 | 249 | 0.010 |
Why?
| | Acetates | 1 | 1977 | 100 | 0.010 |
Why?
| | Models, Chemical | 3 | 1985 | 265 | 0.010 |
Why?
| | Milk | 1 | 1977 | 120 | 0.010 |
Why?
| | Patient Compliance | 1 | 2000 | 565 | 0.010 |
Why?
| | Kidney Papillary Necrosis | 1 | 1975 | 1 | 0.010 |
Why?
| | Pericarditis | 1 | 1975 | 11 | 0.010 |
Why?
| | Agranulocytosis | 1 | 1975 | 30 | 0.010 |
Why?
| | Athetosis | 1 | 1974 | 7 | 0.010 |
Why?
| | Chorea | 1 | 1974 | 11 | 0.010 |
Why?
| | Myoclonus | 1 | 1974 | 13 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 1987 | 5406 | 0.010 |
Why?
| | Health Education | 1 | 1978 | 334 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 1987 | 2004 | 0.010 |
Why?
| | Levallorphan | 1 | 1974 | 1 | 0.010 |
Why?
| | Nalorphine | 1 | 1974 | 1 | 0.010 |
Why?
| | Heart Block | 1 | 1974 | 40 | 0.010 |
Why?
| | Hyperkalemia | 1 | 1974 | 24 | 0.010 |
Why?
| | Nitrosourea Compounds | 1 | 1973 | 1 | 0.010 |
Why?
| | Cytochrome Reductases | 1 | 1973 | 3 | 0.010 |
Why?
| | Riboflavin | 1 | 1973 | 7 | 0.010 |
Why?
| | Flavin Mononucleotide | 1 | 1973 | 7 | 0.010 |
Why?
| | Binding Sites | 2 | 1976 | 1252 | 0.010 |
Why?
| | Temperature | 1 | 1977 | 636 | 0.010 |
Why?
| | Histamine H1 Antagonists | 1 | 1973 | 29 | 0.010 |
Why?
| | Flavin-Adenine Dinucleotide | 1 | 1973 | 14 | 0.010 |
Why?
| | Macaca | 1 | 1973 | 54 | 0.010 |
Why?
| | Haplorhini | 1 | 1973 | 50 | 0.010 |
Why?
| | Potassium | 1 | 1974 | 143 | 0.010 |
Why?
| | Mixed Function Oxygenases | 1 | 1973 | 41 | 0.010 |
Why?
| | Neurologic Examination | 1 | 1973 | 115 | 0.010 |
Why?
| | Water | 1 | 1977 | 448 | 0.010 |
Why?
| | Drug Tolerance | 1 | 1973 | 90 | 0.010 |
Why?
| | Heme | 1 | 1973 | 77 | 0.010 |
Why?
| | Aniline Compounds | 1 | 1973 | 98 | 0.010 |
Why?
| | Methyltransferases | 1 | 1973 | 70 | 0.010 |
Why?
| | Antidepressive Agents | 1 | 1974 | 228 | 0.010 |
Why?
| | Organ Size | 1 | 1973 | 447 | 0.010 |
Why?
| | Phospholipids | 1 | 1973 | 215 | 0.010 |
Why?
| | NADP | 1 | 1971 | 46 | 0.010 |
Why?
| | Pre-Eclampsia | 1 | 1973 | 186 | 0.010 |
Why?
| | Plants | 1 | 1973 | 217 | 0.010 |
Why?
| | Cystic Fibrosis | 1 | 1981 | 1053 | 0.010 |
Why?
| | Chickenpox | 1 | 1972 | 80 | 0.010 |
Why?
| | Suicide | 2 | 1976 | 580 | 0.010 |
Why?
| | Safety | 1 | 1993 | 331 | 0.010 |
Why?
| | Hypoglycemia | 1 | 1975 | 427 | 0.010 |
Why?
| | Glioblastoma | 1 | 1973 | 326 | 0.010 |
Why?
| | Body Weight | 1 | 1973 | 940 | 0.000 |
Why?
| | Pulmonary Edema | 2 | 1981 | 106 | 0.000 |
Why?
| | Herpes Zoster | 1 | 1972 | 317 | 0.000 |
Why?
| | Hyperkinesis | 1 | 1987 | 17 | 0.000 |
Why?
| | Brain Neoplasms | 2 | 1973 | 1171 | 0.000 |
Why?
| | Monoamine Oxidase Inhibitors | 1 | 1984 | 15 | 0.000 |
Why?
| | Guinea Pigs | 1 | 1964 | 157 | 0.000 |
Why?
| | Soft Tissue Neoplasms | 1 | 1985 | 112 | 0.000 |
Why?
| | Virulence | 1 | 1964 | 255 | 0.000 |
Why?
| | Structure-Activity Relationship | 1 | 1984 | 548 | 0.000 |
Why?
| | Sarcoma | 1 | 1985 | 176 | 0.000 |
Why?
| | Neuromuscular Diseases | 1 | 1984 | 105 | 0.000 |
Why?
| | Foreign-Body Migration | 1 | 1983 | 35 | 0.000 |
Why?
| | Antineoplastic Agents | 1 | 1973 | 2061 | 0.000 |
Why?
| | Rats, Inbred Strains | 1 | 1981 | 368 | 0.000 |
Why?
| | Drug Evaluation, Preclinical | 1 | 1981 | 171 | 0.000 |
Why?
| | Infant, Low Birth Weight | 1 | 1981 | 135 | 0.000 |
Why?
| | Health Occupations | 1 | 1980 | 30 | 0.000 |
Why?
| | Respiration Disorders | 1 | 1981 | 72 | 0.000 |
Why?
| | Biological Availability | 1 | 1980 | 147 | 0.000 |
Why?
| | Skin Absorption | 1 | 1979 | 12 | 0.000 |
Why?
| | Medicine, Traditional | 1 | 1979 | 22 | 0.000 |
Why?
| | Accidents, Occupational | 1 | 1979 | 13 | 0.000 |
Why?
| | Fires | 1 | 1981 | 88 | 0.000 |
Why?
| | Anti-Arrhythmia Agents | 1 | 1979 | 111 | 0.000 |
Why?
| | Electric Stimulation Therapy | 1 | 1979 | 77 | 0.000 |
Why?
| | Shock | 1 | 1979 | 92 | 0.000 |
Why?
| | Podophyllotoxin | 1 | 1978 | 7 | 0.000 |
Why?
| | Condylomata Acuminata | 1 | 1978 | 7 | 0.000 |
Why?
| | Vulvar Neoplasms | 1 | 1978 | 12 | 0.000 |
Why?
| | Heart | 1 | 1982 | 637 | 0.000 |
Why?
| | Pacemaker, Artificial | 1 | 1979 | 110 | 0.000 |
Why?
| | Gestational Age | 1 | 1981 | 874 | 0.000 |
Why?
| | Administration, Topical | 1 | 1978 | 145 | 0.000 |
Why?
| | Neoplasms | 1 | 1972 | 2470 | 0.000 |
Why?
| | Neurologic Manifestations | 1 | 1976 | 3 | 0.000 |
Why?
| | Renal Dialysis | 1 | 1981 | 423 | 0.000 |
Why?
| | Vision Disorders | 1 | 1978 | 135 | 0.000 |
Why?
| | Carbon Radioisotopes | 1 | 1976 | 35 | 0.000 |
Why?
| | Mathematics | 1 | 1976 | 102 | 0.000 |
Why?
| | Isotope Labeling | 1 | 1976 | 74 | 0.000 |
Why?
| | Quality of Health Care | 1 | 1980 | 608 | 0.000 |
Why?
| | Referral and Consultation | 1 | 1980 | 732 | 0.000 |
Why?
| | Remission, Spontaneous | 1 | 1973 | 38 | 0.000 |
Why?
| | Blood Platelet Disorders | 1 | 1973 | 10 | 0.000 |
Why?
| | Recurrence | 1 | 1977 | 1007 | 0.000 |
Why?
| | Radionuclide Imaging | 1 | 1973 | 123 | 0.000 |
Why?
| | Astrocytoma | 1 | 1973 | 122 | 0.000 |
Why?
| | Dinitrophenols | 1 | 1972 | 8 | 0.000 |
Why?
| | Complement Fixation Tests | 1 | 1972 | 6 | 0.000 |
Why?
| | Immune Sera | 1 | 1972 | 86 | 0.000 |
Why?
| | Splenectomy | 1 | 1972 | 58 | 0.000 |
Why?
| | Ependymoma | 1 | 1973 | 177 | 0.000 |
Why?
| | Medulloblastoma | 1 | 1973 | 198 | 0.000 |
Why?
| | Neoplasm Metastasis | 1 | 1973 | 610 | 0.000 |
Why?
| | Lymphoma | 1 | 1972 | 196 | 0.000 |
Why?
| | Blood Platelets | 1 | 1973 | 380 | 0.000 |
Why?
| | Hodgkin Disease | 1 | 1972 | 134 | 0.000 |
Why?
| | Leukemia | 1 | 1972 | 230 | 0.000 |
Why?
| | Herpesvirus 3, Human | 1 | 1972 | 331 | 0.000 |
Why?
| | Chronic Disease | 1 | 1973 | 1720 | 0.000 |
Why?
| | Staphylococcal Infections | 1 | 1972 | 393 | 0.000 |
Why?
|
|
Rumack's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|